Xiang Kong Selected Research

sesamin

10/2015	Sesamin enhances nitric oxide bioactivity in aortas of spontaneously hypertensive rats.
1/2015	Suppression of TGF-β1/Smad signaling pathway by sesamin contributes to the attenuation of myocardial fibrosis in spontaneously hypertensive rats.
7/2014	Differentiation therapy: sesamin as an effective agent in targeting cancer stem-like side population cells of human gallbladder carcinoma.
2/2013	Long-term intake of sesamin improves left ventricular remodelling in spontaneously hypertensive rats.
5/2012	Sesamin exerts renoprotective effects by enhancing NO bioactivity in renovascular hypertensive rats fed with high-fat-sucrose diet.
10/2009	Sesamin improves endothelial dysfunction in renovascular hypertensive rats fed with a high-fat, high-sucrose diet.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiang Kong Research Topics

Disease

9	Chronic Kidney Failure (Chronic Renal Failure) 01/2018 - 09/2014
7	Neoplasms (Cancer) 07/2019 - 01/2008
5	Fibrosis (Cirrhosis) 01/2021 - 02/2013
4	Hypertension (High Blood Pressure) 02/2016 - 10/2009
3	Neuroinflammatory Diseases 01/2021 - 01/2016
3	Type 2 Diabetes Mellitus (MODY) 01/2019 - 11/2014
3	Anemia 11/2017 - 09/2014
3	Gallbladder Neoplasms (Gallbladder Cancer) 01/2016 - 07/2014
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2022 - 01/2008
2	Hyperglycemia 01/2021 - 04/2017
2	Hepatic Encephalopathy 01/2021 - 12/2014
2	Lung Injury 07/2019 - 07/2007
2	Insulin Resistance 01/2019 - 05/2018
2	Hypertrophy 01/2019 - 02/2013
2	Body Weight (Weight, Body) 01/2019 - 02/2013
2	Hypoxia (Hypoxemia) 11/2015 - 01/2009
2	Cognitive Dysfunction 10/2015 - 12/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2014 - 01/2011
2	Acute Lung Injury 01/2009 - 02/2008
1	Aortic Dissection 06/2022
1	Tics (Tic) 06/2022
1	Pre-Eclampsia (Preeclampsia) 05/2022
1	Diabetic Cardiomyopathies 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Myocarditis (Carditis) 01/2020
1	Paralysis (Palsy) 01/2020
1	Necrosis 07/2019
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2019
1	Follicular Cyst (Follicular Cysts) 01/2019
1	Cardiomegaly (Heart Hypertrophy) 01/2019
1	Non-alcoholic Fatty Liver Disease 05/2018
1	Nephrotic Syndrome (Syndrome, Nephrotic) 04/2018
1	Acute Kidney Injury (Acute Renal Failure) 04/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2017
1	Hemorrhage 09/2017
1	Placenta Previa 09/2017
1	Placenta Accreta 09/2017

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2009
6	sesaminIBA 10/2015 - 10/2009
4	Long Noncoding RNAIBA 05/2022 - 11/2015
3	Biological ProductsIBA 02/2022 - 11/2015
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 05/2017
3	Advanced Glycation End ProductsIBA 01/2020 - 01/2017
3	Pyruvaldehyde (Methylglyoxal)IBA 01/2020 - 11/2014
3	Insulin (Novolin)FDA Link 01/2020 - 05/2018
3	Blood Glucose (Blood Sugar)IBA 01/2019 - 10/2017
3	CreatinineIBA 01/2016 - 09/2014
3	Urea (Carbamide)FDA LinkGeneric 01/2016 - 09/2014
2	Oxidoreductases (Dehydrogenase)IBA 01/2021 - 01/2020
2	AmmoniaIBA 11/2017 - 08/2014
2	Hemoglobins (Hemoglobin)IBA 01/2016 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 12/2014 - 09/2013
2	Losartan (Cozaar)FDA LinkGeneric 09/2014 - 01/2011
2	Pioglitazone (Actos)FDA Link 09/2014 - 01/2011
1	AmberIBA 06/2022
1	WastewaterIBA 06/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2022
1	Circular RNAIBA 02/2022
1	Transforming Growth Factor-beta Type I ReceptorIBA 02/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021
1	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 01/2021
1	dapagliflozinIBA 01/2021
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	ThioredoxinsIBA 01/2020
1	Cytochromes c (Cytochrome c)IBA 01/2020
1	2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA 07/2019
1	salicylhydroxamic acid (SHAM)IBA 07/2019
1	Glutathione PeroxidaseIBA 07/2019
1	Adenosine (Adenocard)FDA LinkGeneric 07/2019
1	Therapeutic UsesIBA 07/2019
1	CytokinesIBA 01/2019
1	resiniferatoxinIBA 01/2019
1	Dehydroepiandrosterone (DHEA)IBA 01/2019
1	Nonesterified Fatty Acids (NEFA)IBA 01/2019
1	FlavonoidsIBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	Minocycline (Cyclops)FDA LinkGeneric 10/2018
1	Thioacetamide (Thioacetamid)IBA 10/2018
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2018
1	Molecular Probes (Molecular Probe)IBA 10/2018
1	Triglycerides (Triacylglycerol)IBA 05/2018
1	shengliIBA 05/2018
1	AndrogensIBA 05/2018
1	CholesterolIBA 05/2018
1	Follicle Stimulating Hormone (Follitropin)FDA Link 05/2018
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 05/2018
1	HDL LipoproteinsIBA 05/2018
1	Sex Hormone-Binding GlobulinIBA 05/2018
1	Testosterone (Sustanon)FDA Link 05/2018
1	Dehydroepiandrosterone SulfateIBA 05/2018
1	Contrast MediaIBA 04/2018
1	oridoninIBA 11/2017

Therapy/Procedure

7	Renal Dialysis (Hemodialysis) 01/2017 - 09/2014
5	Therapeutics 01/2017 - 01/2008
2	Kidney Transplantation 01/2018 - 02/2016
2	Peritoneal Dialysis 01/2016 - 01/2016
1	Cannula 06/2022
1	Hysterectomy 09/2017
1	Cesarean Section (Caesarean Section) 09/2017